The Partners in Bleeding Disorders Education Program promotes excellence in care through education, created by and for the federally-recognized Hemophilia Treatment Center (HTC) Network and providers from a variety of disciplines that serve patients…
Hemophilia A and B are classified as rare disorders in the United States, affecting fewer than 200,000 individuals. Even rarer bleeding and clotting disorders, often referred to as rare or ultra‑rare coagulation disorders, affect far fewer people…
The NBDF-Takeda Clinical Fellowship Program, funded through the generous support of Takeda, is intended to increase the number of skilled clinicians committed to providing comprehensive care for individuals with bleeding disorders.…
American Society of Hematology (ASH)
With more than 18,000 members from nearly 100 countries, the ASH is the world's largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases…
What is the hemophilia treatment center (HTC) model of care?
HTCs provide patient-centered, comprehensive care to assess and provide treatment for the long-term complications of bleeding disorders throughout an individual’s life. The HTCs…